Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907).
Ruddy, K J
Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907). [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Dec 2012 - 3075-3081 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
1569-8041
10.1093/annonc/mds133 doi
Age Factors
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Breast Neoplasms--drug therapy
Capecitabine
Chemotherapy, Adjuvant--adverse effects
Cyclophosphamide--adverse effects
Deoxycytidine--adverse effects
Female
Fluorouracil--adverse effects
Humans
Medication Adherence
Methotrexate--adverse effects
Patient Compliance
Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907). [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Dec 2012 - 3075-3081 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
1569-8041
10.1093/annonc/mds133 doi
Age Factors
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Breast Neoplasms--drug therapy
Capecitabine
Chemotherapy, Adjuvant--adverse effects
Cyclophosphamide--adverse effects
Deoxycytidine--adverse effects
Female
Fluorouracil--adverse effects
Humans
Medication Adherence
Methotrexate--adverse effects
Patient Compliance